利奈唑胺在住院儿童中的应用。
Linezolid use in hospitalized children.
作者信息
Hersh Adam L, Lee Brian R, Hedican Erin B, Herigon Josh C, Newland Jason G
机构信息
From the *Pediatric Infectious Diseases, University of Utah, Salt Lake City, UT and †Children's Mercy Hospital and Clinics, Kansas City, MO.
出版信息
Pediatr Infect Dis J. 2014 Jan;33(1):e14-8. doi: 10.1097/INF.0000000000000011.
We used the Pediatric Health Information System to evaluate linezolid use among hospitalized children. From 2003 to 2007, use increased 5-fold, including wide interhospital variation, then stabilized through 2011. Linezolid was responsible for 3% of total antibiotic expenditures. Children with respiratory, oncologic or transplant conditions were the most frequently treated with linezolid.
我们使用儿科健康信息系统来评估住院儿童中利奈唑胺的使用情况。2003年至2007年期间，其使用量增长了5倍，包括医院间存在很大差异，然后在2011年之前趋于稳定。利奈唑胺占抗生素总支出的3%。患有呼吸道、肿瘤或移植疾病的儿童是最常使用利奈唑胺治疗的。
Zotero 插件